TransMedics Group Investor Relations Material

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. It develops Organ Care System platform that enables the assessment of donor organ viability, the maintenance of donor organ function, and intervention in the organ procurement process for use in lung, heart, kidney and liver transplantations.